1. A report by Cereda et al'4 highlights one of the problems associated with non-secretory myeloma, in which, by definition, a serum or urinary paraprotein cannot be identified. In their case an erroneous diagnosis of breast carcinoma was made partly;D, Kumaratne D.S.; JB, Forrester; A, Lamont; DI, Stott;J Immunol Methods; The application of isoelectric focusing to routine screening for paraproteinaemia,1983
2. The detection and identification of serum monoclonal immunoglobulin by immunoisoelectric focusing. Limits of sensitivity and use during relapse of multiple myeloma;Sinclair, D.; Kumaratne, D.S.; Stott, D.I.;J Clin Pathol,1984
3. Improved survival times in multiple myeloma treated with melphelan, prednisolone, cyclophosphamide, vincristine, and BCNU: M2 protocol;Case, D.C.; Lee, B.J.; Clarkson, B.D.;Am J Med,1977
4. Plasma cell myeloma: gamma globulin synthesis and structure;Osserman, E.F.; Takatsuki, K.;Medicine,1963
5. Immunochemical classes of myelomatosis;Hobbs, JR;Br J Haematol,1969